# Attovia Therapeutics, Inc. (ATTO): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Attovia Therapeutics, Inc. (ATTO) is 9/100, ranked against 24,000+ stocks in 35 markets (Quality 28, Value 23, Momentum 29, each scored against its sector).

- StockRank: 9/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 28, Value 23, Momentum 29: each a 0-100 percentile within Healthcare.
- Position: #24,193 overall, #2,348 in Healthcare.
- Listing: United States, NGM; Healthcare / Biotechnology.
- Last close: 13.88 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 10.3M; directors sold USD 2.2M; 5%+ holders bought USD 31.8M.

Source: https://moatmap.ai/stock/ATTO
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker